Introduction

Gordon Smith: I'm a neuromuscular neurologist and professor at Virginia Commonwealth University. Frederick Peel is an internationally renowned expert in neuroimmunology, both multiple sclerosis and will be talking about my isenia gravis today. He's the author of a really important and interesting study that was just published in germinerology called efficacy and safety of retuximab for new onset generalized myosenia gravis.